Background Angiopeptin, a synthetic cyclic octapeptide analogue of somatostatin, reduces neointimal hyperplasia after balloon denudation of rabbit aorta if administered before injury. The aim of this study was to analyze the effect of angiopeptin pretreatment on the level of expression of the c-fos and c-jun protooncogenes, early markers of smooth muscle cell proliferation, after balloon denudation of rabbit aorta.
Methods and Results For histological analysis of the effect of angiopeptin on neointimal thickening after aortic balloon denudation, rabbits were randomized into three groups: group 1 (controls), twice-daily injections of saline begun 24 hours before balloon denudation (n=9); group 2, twice-daily injections of angiopeptin 10 ug/kg begun 24 hours before balloon denudation (n=9); and group 3, twice-daily injections of angiopeptin 10 ug/kg begun 1 hour after balloon denudation (n=7). The degree of neointimal thickening 28 days after balloon denudation was significantly less in group 2 than in group 1 (neointimal area: group 1, 0.59±0.11 mm2; group 2, 0.22±0.05 mm2; P<.05. Neointima/media: group 1, 0.85±0.17; group 2, 0.23±0.05; P<.05). When angiopeptin was started 1 hour after denudation (group 3), however, the neointimal area (0.52+0.09 mm2) and the neointima/media ratio (0.76±0. 10) were not statistically different from the control group. For analysis of protooncogene induction, rabbits received twicedaily subcutaneous injections of saline (n=7), angiopeptin 10 jig/kg (n=8), or angiopeptin 100 1Lg/kg (n=4) begun 
Methods

Balloon Denudation
Male New Zealand White rabbits (2 to 2.5 kg) were used in all experiments. The animals were anesthetized with ethyl carbamate (1 g/kg IV). After exposure of the right femoral artery, a 3F Fogarty balloon catheter was passed retrogradely to a distance of 25 cm and inflated until contact was made with the endothelium. The aortas were denuded by gentle advancement and withdrawal of the catheter three times.911 The femoral artery was subsequently ligated and the wound closed. All the studies described conform to the position of the American Heart Association on research animal use.
Study Groups Analysis of Protooncogene Induction After Injury
Eight rabbits were killed at various times (30 minutes, 1 hour, 2 hours, and 5 hours) after balloon denudation. Another group of eight animals who underwent a sham operation served as controls.
Effects ofAngiopeptin on Protooncogene Induction
To investigate the effects of angiopeptin, 15 rabbits were randomized to receive twice-daily subcutaneous injections of either 0.5 mL saline (n=7) or angiopeptin 10 ptg/kg (n=8). A third group of animals received twice-daily injections of angiopeptin 100 gtg/kg (n=4). Angiopeptin was provided by Ipsen Biotech. Aortic balloon denudation was performed on the second day of treatment, 2 hours after the third injection of angiopeptin or of saline. The animals were killed 30 minutes after balloon denudation.
Effects ofAngiopeptin on Neointimal Thickening 28 Days After Injury
To analyze the in vivo inhibitory effect of angiopeptin on neointimal thickening after balloon denudation, 25 rabbits were randomized into three groups to receive the following treatment regimens: group 1, twice-daily subcutaneous injections of 0.5 mL saline begun 24 hours before balloon denudation (n=9); group 2, twice-daily injections of angiopeptin 10 Lg/kg begun 24 hours before balloon denudation (n=9); and group 3, twicedaily injections of angiopeptin 10 pg/kg begun 1 hour after balloon denudation (n=7). The animals were killed 28 days after balloon denudation for histological analysis.
RNA Extraction and Northern Blot Analysis
Immediately after the animals were killed, the abdominal aorta was removed, stripped of periaortic fat and connective tissue, and frozen in liquid nitrogen until assayed. RNA extraction was performed by the technique described by Chomczynski and Sacchi.'3 Northern blot analysis (using 25 to 30 jig total RNA per lane) was performed as previously described.14,15 The RNA content was verified by use of ethidium bromide. Blots were hybridized with a fos probe (1.06-kb Pst I fragment, corresponding to a v-fos)16 or a jun probe (2.1-kb EcoRI and Puv II fragment, corresponding to a v-jun).17 In addition, blots were hybridized with the constitutive probe specific for 18S ribosomal RNA to monitor the RNA content of the different lanes. The probes were labeled with [32P]dCTP by use of the multiprime DNA labeling reaction kit (Amersham Corp). Hybridization was carried out for 12 to 16 hours at 42°C as previously described.14 The membranes were washed for two 10-minute periods in 200 mL of 2x standard sodium citrate (SSC)/0.1% SDS at room temperature and then for two 15-minute periods in 0.1 x SSC/ 0. 1% SDS at 50°C. Autoradiography was performed with Dupont Cronex 4 x-ray films at -70°C for 1 to 3 days.
The relative abundance of specific mRNA transcripts was quantified by radioanalytic scanning with a spectrophotometric scanner (Schimadzu Corp). The results were expressed as a fraction of the levels of 18S ribosomal RNA in relative densitometric units. 
Histological Analysis
The vessels were perfusion-fixed with 4% paraformaldehyde (in a saline phosphate buffer solution) at a pressure of 110 mm Hg as previously described.18 After further immersion in 4% paraformaldehyde for 24 hours, the vessels were embedded in paraffin. Aortic cross sections were cut and stained with hematoxylin-eosin-saffron-astra blue or with Mallory's phosphotungstic hematoxylin. Morphometric analysis of the histological cross sections was performed with digital microscopic planimetry (Morphometry-System, Biocom). We analyzed three histological cross sections per aorta (2 cm below the junction of the aorta with the lower renal artery, 2 cm above the aortoiliac bifurcation, and midway between these two points). The mean areas of the neointima and of the media (in square millimeters) were calculated. The neointima/media ratio was defined as the neointimal area divided by the area of the media. All these measurements were performed by a pathologist who was unaware of the design of the protocol.
Statistical Analysis
Results are expressed as mean±SEM. The Mann-Whitney rank-sum test was used for between-group comparisons of mean levels of protooncogene expression, expressed in relative densitometric units. Differences in intimal thickening were assessed by ANOVA. A value of P<.05 was considered to indicate statistical significance.
Results
Oncogene Induction
Representative examples of the results of RNA hybridization with the c-fos and c-jun probes 30 minutes, 1 hour, 2 hours, and 5 hours after balloon denudation are shown in Fig 1. In sham-operated animals, c-jun was expressed at very low levels, and expression of c-fos was not detected. After balloon denudation, expression of the two protooncogenes was evident at 30 minutes, remained at a high level at 1 and 2 hours, but was undetectable at 5 hours.
Effects of Angiopeptin on Protooncogene Induction
Representative examples of the results of RNA hybridization with the two probes 30 (Table) . By contrast, when the angiopeptin treatment was begun 1 contrast, if the angiopeptin treatment was begun 1 hour after injury, no effect on neointimal thickening was observed. These findings suggest that the inhibitory effect of angiopeptin in this model may be related, at least in part, to an inhibitory effect on early (G1) events of the cell cycle.
We and others have previously demonstrated that balloon denudation of rabbit aorta, as performed in the present study, causes complete deendothelialization and that smooth muscle proliferation, migration, and intimal thickening subsequently occur.9 l0,18 The activation of nuclear oncogenes occurs at a very early stage in this process.1112 '18 It has recently been demonstrated that the distribution of c-fos and c-jun products after balloon injury of rat aorta was concentrated in smooth muscle cell nuclei. 19 The induction of nuclear oncogenes is one of the earliest transcriptional events associated with growth factor stimulation, and the increased expression of these genes is a transient response to mitogenic stimulation persisting for at most a few hours after exposure to growth factors.2012 The protooncogenes c-fos and c-jun are two prominent members of the nuclear oncogene family. The corresponding oncoproteins function together as a dimeric complex that binds to a specific DNA consensus sequence (AP-1) of target genes to stimulate their transcription and are involved in the G1 phase of the cell cycle.22 Experiments in cell culture models have shown that the use of antibodies or of antisense RNA against nuclear oncogenes prevents cell entry into the S phase and the subsequent synthesis of DNA.23,24 It is therefore plausible that this expression of nuclear oncogenes in the hours after angioplasty is associated with the early G1 events preceding DNA synthesis in smooth muscle cells.
Previous studies9'1025'26 have shown that angiopeptin specifically inhibits the growth of vascular smooth muscle cells after arterial injury. Using the same experimental model of balloon denudation of rabbit aorta, Conte et a19 demonstrated a significant reduction in neointimal thickening 3 weeks after injury in animals treated with 10 ug/kg of angiopeptin twice daily compared with control animals. Asotra et a126 showed that 100 Lg/kg of angiopeptin twice daily markedly inhibits [3H]thymidine incorporation into balloon-denuded rabbit aorta, thus demonstrating that the effect of angiopeptin on neointimal formation is due to inhibition of vascular smooth muscle cell proliferation. Moreover Although animal models of myointimal proliferation, such as balloon injury of normal arterial segments, do not reproduce the clinical situation, they provide valuable insights into potential mechanisms of cell growth regulation. The potential of candidate drugs for the prevention of restenosis in animal models is generally assessed by the determination of their effect on neointimal proliferation. The recognition that events ultimately associated with neointimal proliferation are detectable in the hours after balloon injury provides another potentially useful method to assess possible antiproliferative activity. To the best of our knowledge, our findings are the first demonstration of an inhibitory drug effect on the early steps of the vascular wall response to injury. Interestingly, a relatively low dose of 20 ,ug * kg`-l d-was sufficient to obtain a significant inhibition with no apparent additional benefit for higher doses; this is of great potential clinical relevance, since there are usually marked discrepancies between the doses of drugs used in animal models of restenosis and the doses used in clinical trials in humans. Clinically relevant doses of angiopeptin are similar to those we used in our experimental study. Finally, the demonstrated inhibitory effect of angiopeptin as early as 30 minutes after injury emphasizes the need for pretreatment to maximize a potential beneficial effect on restenosis.
